RetractedArticleFrontiers in oncology2020

Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.

Bo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.